10-Q: 180 Life Sciences Reports Q1 2025 Results, Navigates Strategic Shift Towards iGaming
Sentiment:
Quarterly Report
180 Life Sciences reports a net loss for Q1 2025 while strategically shifting focus to the online gaming industry and managing legacy biotechnology assets.
Capital raiseThe company states that it needs to raise a significant amount of capital in order to pay its debts and cover its operating costs.The company anticipates that it will need to issue equity to fund its operations and fund its operating expenses for the foreseeable future.The company plans to seek to raise funding in the future to support its operations, and to pay amounts due to Oxford, through a combination of equity offerings, debt financing or other capital sources, including potentially collaborations, licenses and other similar arrangements, which may not be available on favorable terms, if at all.
Worse than expectedThe company's net loss increased from $1.1 million in Q1 2024 to $2.4 million in Q1 2025.The company's accumulated deficit increased to $143.9 million as of March 31, 2025.The company's cash balance is expected to last only until December 2025, raising concerns about its ability to continue as a going concern.
Summary
- 180 Life Sciences Corp. reported its financial results for the quarter ended March 31, 2025.
- The company is strategically entering the online gaming industry, utilizing blockchain technology and cryptocurrency operability.
- 180 Life Sciences is evaluating strategic options for its TNF and CBD programs, including potential sale or disposition.
- The company had an accumulated deficit of $143.9 million as of March 31, 2025, and a net loss of $2.4 million for the quarter.
- Cash used in operating activities was $853,723 for the three months ended March 31, 2025.
- The company believes its current cash will fund operations through December 2025.
- Management is taking steps to develop and enhance its internal controls over financial reporting.
- The company is in discussions with the University of Oxford regarding outstanding payments.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the increased net loss, accumulated deficit, and concerns about the company's ability to continue as a going concern. However, the strategic shift to iGaming and efforts to regain Nasdaq compliance provide some positive aspects.
Positives
- The company is strategically entering the online gaming industry, potentially opening new revenue streams.
- Research and development expenses decreased year-over-year, indicating cost management.
- The company has taken steps to regain compliance with Nasdaq listing requirements.
- The company settled litigation with AmTrust and Tyche Capital LLC, resolving outstanding legal issues.
- The company is actively evaluating strategic transactions to maximize shareholder value.
Negatives
- The company reported a net loss of $2.4 million for Q1 2025, an increase from the $1.1 million loss in Q1 2024.
- The company has a significant accumulated deficit of $143.9 million.
- The company's cash balance is expected to last only until December 2025, raising concerns about its ability to continue as a going concern.
- General and administrative expenses increased year-over-year.
- The company is in discussions with the University of Oxford regarding outstanding payments, and Oxford may take legal action against the company.
Risks
- The company's ability to continue as a going concern is dependent on raising additional capital.
- The company faces risks associated with entering the online gaming industry, including regulatory compliance and competition.
- The company's stock price is highly volatile and may be subject to wide fluctuations.
- Elray Resources, Inc., beneficially owns a significant percentage of the company's common stock and may be able to exercise significant voting control over the company.
- The company owes a significant amount of money to the University of Oxford, which may take action against the company to enforce their rights to payment in the future.
- If the company makes any acquisitions, they may disrupt or have a negative impact on the company's business.
- The company's disclosure controls and procedures were not effective as of March 31, 2025.
Future Outlook
The company expects to invest a significant amount of capital to commercialize its iGaming assets and fund research and development, and believes its current cash will fund operations through December 2025.
Management Comments
- Management believes that the combination of the Gaming Technology Platform and the strength of a Nasdaq listing make the Company an attractive consolidation vehicle for the iGaming industry.
- Management is committed to taking further action and implementing necessary enhancements or improvements to develop and enhance its internal controls over financial reporting.
Industry Context
The company is strategically entering the online gaming industry, which is a growing market with potential for significant revenue generation. The company's focus on blockchain technology and cryptocurrency operability aligns with current trends in the iGaming market.
Comparison to Industry Standards
- The document does not provide enough information to compare the company's results to global benchmarks.
- The document does not provide enough information to compare the company's results to specific comparable companies or projects.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Accounting Officer (Principal Accounting/Financial Officer) | Blair Jordan | Eric R. Van Lent | 2025-02-15 | Appointment of new Chief Accounting Officer |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Appointment | Appointment of independent director Ryan Smith as Lead Independent Director of the Company | 2025-02-04 | Enhances board independence and oversight |
Legal Proceedings
- The company is involved in ongoing litigation with AmTrust, which has been settled.
- The company is involved in ongoing litigation with the University of Oxford regarding outstanding payments.
- The company is involved in ongoing litigation with Elray Resources, Inc., and Luxor Capital, LLC, which has been settled.
Related Party Transactions
- Research and development expenses related to related parties were $135,455 for the three months ended March 31, 2025.
- Elray Resources, Inc., beneficially owns a significant percentage of the company's common stock and may be able to exercise significant voting control over the company.
- Mr. Jay Goodman, a director of the Company, is the adult son of Mr. Anthony Brian Goodman, who serves as the Chief Executive Officer of Elray and is deemed to beneficially own the securities held by Elray in the Company.
Stakeholder Impact
- Shareholders face potential dilution from future equity offerings.
- Employees may be affected by cost-cutting measures or changes in business strategy.
- Customers may be impacted by the company's shift to iGaming and potential changes in product offerings.
- Suppliers and creditors may be affected by the company's financial condition and ability to meet its obligations.
Next Steps
- The company plans to commercialize its iGaming assets.
- The company plans to evaluate strategic options for its TNF and CBD programs.
- The company plans to continue discussions with the University of Oxford regarding outstanding payments.
- Management expects to complete an assessment of the design and operating effectiveness of its internal controls over financial reporting during the second half of 2025.
Key Dates
| Date | Description |
|---|---|
| 2016-09-07 | 180 Life Sciences Corp. was organized under the laws of the State of Delaware. |
| 2018-03-07 | Katexco was incorporated under the provisions of the British Corporation Act of British Columbia. |
| 2018-03-08 | CBR Pharma was incorporated under the provisions of the British Corporation Act of British Columbia. |
| 2019-01-28 | 180 Life Corp. was incorporated in the State of Delaware. |
| 2019-05-31 | Katexco Callco, ULC, Katexco Purchaseco, ULC, CannBioRex Callco, ULC, and CannBioRex Purchaseco, ULC were formed in the Canadian Province of British Columbia. |
| 2021-07-01 | The assets and liabilities of the Canadian companies (Katexco and CBR Pharma) were transferred to their respective subsidiaries, which are Katexco Pharmaceuticals Corp. (Katexco U.S.) and CannBioRex Pharma Limited (CBR Pharma U.K.). |
| 2024-09-29 | The Company entered into an Asset Purchase Agreement with Elray Resources, Inc. |
| 2024-09-30 | The purchase of the Purchased Assets closed. |
| 2024-11 | The biotechnology related to 7nAChR was returned to Stanford University. |
| 2024-12-27 | The Conversion Rate was fixed at 1.318 or 1,318,000 total shares of common stock. |
| 2025-02-21 | The Company entered into a Mutual Settlement and General Release Agreement with Dr. Marlene Krauss and KBL IV Sponsor, LLC. |
| 2025-03-27 | Elray Resources, Inc., the sole holder of the Series B Convertible Preferred Stock of the Company converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Company into 1,318,000 shares of common stock. |
| 2025-04-06 | The Company entered into a Confidential Settlement Agreement and Release with AmTrust, and its wholly-owned subsidiary, AmTrust Financial Services, Inc. |
| 2025-04-28 | The Company entered into a Settlement and Mutual Release Agreement with Elray Resources, Inc., and Luxor Capital, LLC. |
| 2025-05-15 | As of this date, 5,695,487 shares of common stock were issued and outstanding. |
Keywords
iGaming, blockchain, online casino, financial results, net loss, accumulated deficit, research and development, capital resources, going concern, 180 Life Sciences
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.